Cannabis Law Report

AUGUST 31, 2021

Alixen™ 30 will target indications such as anxiety, insomnia, Parkinson’s Disease, and depression, while Alixen™ 100 will be used in the treatment of epilepsy.

Chronic Pain 105

Chronic Pain Epilepsy THC Patients 105

The Cannigma

JULY 5, 2022

But it is a medical program in name only, because as of June 2022 there were no licensed dispensaries in Georgia. Despite having 20,000 registered patients in March of 2022, there are no licensed producers or distributors of cannabis products and sales are unlikely to start before mid-2023 at the earliest. Possible penalties.

Law 96

Law Decriminalization Programs Patients 96

Veriheal

MAY 17, 2023

After a two-year break, Singapore’s death penalty was reinforced in early 2022. Despite access restrictions, the government has taken a more relaxed stance towards the usage of medicinal cannabis across the country, which is known for being one of the world’s busiest ports. grams of cannabis in 2017.

Research and Development 96

Research and Development Medicine Treatment Epilepsy 96

Cannabis Law Report

FEBRUARY 19, 2022

The AMCC anticipates that applicants may submit licenses to grow and/or manufacture medical cannabis on September 1, 2022. Under current law , the Florida Department of Health (FDOH) is responsible for overseeing the medical cannabis program, including issuing licenses to medical cannabis treatment centers.

Legalization 97

Legalization Seed-To-Sale Programs Dispensary 97

MMJ Recs

FEBRUARY 9, 2022

So that more people can gain access to the treatment, the Louisiana MMJ program continues to expand, with more qualifying conditions added to the list as well as more cannabis included under the MMJ umbrella. There are various online services that can provide access to an online application in the state of Louisiana.

Marijuana 52

Marijuana Conditions Access Chronic Pain 52

MMJ Recs

MAY 15, 2022

This initial MMJ legislation only allowed patients suffering from intractable epilepsy to use cannabis oil. But in the years since 2017, lawmakers have steadily improved Virginia’s medical marijuana program and made it accessible to a wider range of people. Recently, Virginia legalization has changed in several ways.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

Cannabis Law Report

JUNE 1, 2022

2 June 2022. CBD use is increasing in Western nations, with recent University of Sydney research showing that around 55,000 requests to access medicinal CBD have been approved in Australia since 2016. They completed the task between 45-75 minutes after taking their assigned treatment, and then again at between 3.5

CBD 52

CBD Blood Pressure Sleep Concentrates 52

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

MMJ Recs

SEPTEMBER 15, 2021

A group called Fair Access Missouri has filed a series of potential petitions to legalize recreational MMJ in the state. It is hoped that a vote will happen in 2022. They also provide education and information to patients about MMJ treatment and new products. Who Can Access Missouri Medical Marijuana Dispensaries?

Recreational 52

Recreational Dispensary Conditions Access 52

Cannabis Law Report

SEPTEMBER 1, 2022

AUSTIN, Texas, August 31, 2022 –( BUSINESS WIRE )–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). 1 reason patients seek medical cannabis is to augment their pain management treatment.

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

MMJ Recs

JULY 25, 2022

How do I get a medical card in Michigan in 2022? Once approved, you’ll get provisional access to a licensed dispensary so you can start purchasing MMJ while you wait for your card to arrive. Image by albertoadan on Pixabay : How do I get a medical card in Michigan in 2022? How Can I Get A Medical Marijuana Card In Michigan?

Chronic Pain 52

Chronic Pain Marijuana Recreational Dispensary 52

PrestoDoctor

FEBRUARY 13, 2023

Learn about how to become a medical marijuana patient so you can get access to medical cannabis in Missouri. As of December 8th, 2022, patient/caregiver cultivation ID fees are reduced to $50. The physician must determine if you have had prior treatment failure. However, patients can provide proof of a chronic medical condition.

Marijuana 52

Marijuana Conditions Patients Cultivation 52

Veriheal

MARCH 23, 2023

The people of Japan, a country renowned for its sushi cuisine scene, iconic Mount Fuji, and eye-catching cherry blossom trees, may soon have access to legal medicinal marijuana for intractable diseases. Data suggests that the market has inflated from JPY4 billion (USD$3 billion) in 2019 to JPY17 billion (USD$13 billion) in 2022.

Legalization 66

Legalization Marijuana Clinical Trials Seed-To-Sale 66

Cannabis Law Report

AUGUST 31, 2022

The CUP’s current list of qualifying conditions includes cancer, PTSD, epilepsy and hundreds of neurodegenerative diseases but excludes the many other patients who could benefit from the proven power of medical cannabis to treat chronic pain. 1 reason patients seek medical cannabis is to augment their pain management treatment.

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

Cannabis Law Report

JANUARY 5, 2022

The patent will be issued on January 11, 2022. The issued claims protect the use of MYMD-1 in a method of treatment for the progressive and generalized loss of skeletal muscle mass and strength known as sarcopenia. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Cannabis Law Report

NOVEMBER 16, 2021

Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. Recruitment for the Phase 2 trial will begin immediately, and efficacy data is expected by the end of first quarter of 2022. “To BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

JANUARY 20, 2022

Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Eleusis designed ELE-Psilo, a proprietary psilocybin-based drug candidate that is formulated for IV infusion and in development for the treatment of depression.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

MAY 6, 2022

May 6, 2022. Generally, a CBD product seller is expected (or required by law) to provide customers with access to a “certificate of analysis” or “COA” associated with specific products, which COA confirms the levels of CBD in products and upon which customers can rely. Delta-8 is known to be successful in many cancer treatments.”.

THC 52

THC CBD Media Food 52